
Windlas Biotech Ltd. Members Approve Key Director Appointments
Windlas Biotech Limited announced today, March 20, 2026, that its members have approved the re-appointment of Mr. Ashok Kumar Windlass, Mr. Vivek Dhariwal, and Mr. Gaurav Gulati as Whole-time Director and Independent Directors, respectively, through a postal ballot.The results of the postal ballot, conducted via remote e-voting, were finalized on March 19, 2026. A total of 45,610 shareholders were eligible to vote.
Mr. Ashok Kumar Windlass was re-appointed as Whole-time Director effective May 3, 2026. Mr. Vivek Dhariwal and Mr. Gaurav Gulati were re-appointed as Independent Directors effective May 6, 2026.
Voting Results Summary
| Date of Postal Ballot Notice | February 5, 2026 |
|---|---|
| Cut-off date | February 13, 2026 |
| Voting Start Date & Time | February 18, 2026 (9:00 A.M.) |
| Voting End Date & Time | March 19, 2026 (5:00 P.M.) |
| Total number of shareholders | 45,610 |
Resolution Details
| Resolution No. 1: Re-appointment of Mr. Ashok Kumar Windlass |
|---|
| Total Valid Votes Polled: 15,320,885 |
| Votes in Favour: 13,065,352 (100.00%) |
| Resolution No. 2: Re-appointment of Mr. Vivek Dhariwal |
|---|
| Total Valid Votes Polled: 15,320,885 |
| Votes in Favour: 13,065,352 (100.00%) |
| Resolution No. 3: Re-appointment of Mr. Gaurav Gulati |
|---|
| Total Valid Votes Polled: 15,320,885 |
| Votes in Favour: 13,065,352 (100.00%) |
The voting results and the report from the Scrutinizer, Sandeep Joshi & Associates, are available on the company website (www.windlas.com) and on the MUFG Intime India Private Limited website (www.in.mpms.mufg.com).
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.